About The John R Marsh Cancer Center
"The John R. Marsh Cancer Center is where hope begins for many patients who are battling cancer. Our mission is to heal our patients while helping them continue to live their lives to the fullest. When it comes to treating cancer, we have the most advanced treatments and the best technology available. From nationally renowned oncology specialists to an infusion solarium and meditation garden, our center is the place where patients and families come to find healing, compassion and comfort. And the best part is we are right here providing expert care, close to home®."
Clinical Trials at The John R Marsh Cancer Center
During the past decade, The John R Marsh Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The John R Marsh Cancer Center"
#1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at The John R Marsh Cancer Center
According to Clinical.Site data, the most researched conditions in "The John R Marsh Cancer Center" are
"Carcinoma, Non-Small-Cell Lung" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Lung Cancer" (1 trials), "Non-Small-Cell Lung Adenocarcinoma" (1 trials) and "Non-small Cell Lung Cancer Metastatic" (1 trials). Many other conditions were trialed in "The John R Marsh Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at The John R Marsh Cancer Center
Most popular intervention types in "The John R Marsh Cancer Center" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (1 trials), "Dexamethasone" (1 trials), "Docetaxel" (1 trials), "Ganetespib" (1 trials) and "Ipilimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The John R Marsh Cancer Center
The vast majority of trials in "The John R Marsh Cancer Center" are
3 trials for "All" genders.
Clinical Trials Status at The John R Marsh Cancer Center
Currently, there are NaN active trials in "The John R Marsh Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in The John R Marsh Cancer Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The John R Marsh Cancer Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".